BridgeBio Pharma (BBIO) PT Raised to $89 at JPMorgan
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Price: $76.50 -0.09%
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Rating Summary:
25 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 11 | New: 32
Join SI Premium – FREE
JPMorgan analyst Anupam Rama raised the price target on BridgeBio Pharma (NASDAQ: BBIO) to $89.00 (from $77.00) while maintaining a Overweight rating.
You May Also Be Interested In
- H.C. Wainwright Reiterates Buy Rating on BridgeBio Pharma (BBIO)
- Credo Tech (CRDO) PT Lowered to $310 at JPMorgan, Overweight Rating Maintained
- JPMorgan Downgrades ZTO Express (ZTO) to Overweight
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
